200 related articles for article (PubMed ID: 21897396)
1. Prognostic role of CIP2A expression in serous ovarian cancer.
Böckelman C; Lassus H; Hemmes A; Leminen A; Westermarck J; Haglund C; Bützow R; Ristimäki A
Br J Cancer; 2011 Sep; 105(7):989-95. PubMed ID: 21897396
[TBL] [Abstract][Full Text] [Related]
2. CIP2A overexpression is associated with c-Myc expression in colorectal cancer.
Böckelman C; Koskensalo S; Hagström J; Lundin M; Ristimäki A; Haglund C
Cancer Biol Ther; 2012 Mar; 13(5):289-95. PubMed ID: 22310977
[TBL] [Abstract][Full Text] [Related]
3. CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis.
Fang Y; Li Z; Wang X; Zhang S
Tumour Biol; 2012 Dec; 33(6):2299-306. PubMed ID: 22923389
[TBL] [Abstract][Full Text] [Related]
4. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Khanna A; Böckelman C; Hemmes A; Junttila MR; Wiksten JP; Lundin M; Junnila S; Murphy DJ; Evan GI; Haglund C; Westermarck J; Ristimäki A
J Natl Cancer Inst; 2009 Jun; 101(11):793-805. PubMed ID: 19470954
[TBL] [Abstract][Full Text] [Related]
5. CIP2A is a predictor of poor prognosis in colon cancer.
Teng HW; Yang SH; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Chen PC; Lan YT; Lin CC; Hsu YN; Wang HW; Chen KF
J Gastrointest Surg; 2012 May; 16(5):1037-47. PubMed ID: 22328001
[TBL] [Abstract][Full Text] [Related]
6. The association and prognostic relevance of cancerous inhibitor of protein phosphatase 2A and inflammation in tongue squamous cell carcinoma.
Seppälä M; Tervo S; Pohjola K; Laranne J; Huhtala H; Toppila-Salmi S; Paavonen T
APMIS; 2015 Dec; 123(12):1007-15. PubMed ID: 26522733
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of vasculogenic mimicry, PRRX1, and CIP2A in clear cell renal cell carcinoma and its clinicopathological significance.
Wang X; Yang R; Wang Q; Wang Y; Ci H; Wu S
Medicine (Baltimore); 2019 Sep; 98(36):e17028. PubMed ID: 31490389
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of CIP2A in cholangiocarcinoma and correlation with poor prognosis.
Xu P; Huang Q; Xie F; Xu XL; Shao F
Hepatogastroenterology; 2013 Jun; 60(124):669-72. PubMed ID: 24046827
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of CIP2A in small cell lung cancer patients].
Deng Y; Xie K; Hu H; Yang L; Bai Y
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):517-20. PubMed ID: 26463328
[TBL] [Abstract][Full Text] [Related]
10. Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism.
Wang HW; Yang SH; Huang GD; Lin JK; Chen WS; Jiang JK; Lan YT; Lin CC; Hwang WL; Tzeng CH; Li AF; Yen CC; Teng HW
J Cancer Res Clin Oncol; 2014 Apr; 140(4):561-71. PubMed ID: 24493623
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis.
Li Y; Wang M; Zhu X; Cao X; Wu Y; Fang F
Dis Markers; 2019; 2019():2312439. PubMed ID: 31534561
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor, HER2/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?
Demir L; Yigit S; Sadullahoglu C; Akyol M; Cokmert S; Kucukzeybek Y; Alacacioglu A; Cakalagaoglu F; Tarhan MO
Asian Pac J Cancer Prev; 2014; 15(22):9739-45. PubMed ID: 25520097
[TBL] [Abstract][Full Text] [Related]
13. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
[TBL] [Abstract][Full Text] [Related]
14. High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer.
Böckelman C; Hagström J; Mäkinen LK; Keski-Säntti H; Häyry V; Lundin J; Atula T; Ristimäki A; Haglund C
Br J Cancer; 2011 Jun; 104(12):1890-5. PubMed ID: 21610708
[TBL] [Abstract][Full Text] [Related]
15. NM23 as a prognostic biomarker in ovarian serous carcinoma.
Youn BS; Kim DS; Kim JW; Kim YT; Kang S; Cho NH
Mod Pathol; 2008 Jul; 21(7):885-92. PubMed ID: 18408655
[TBL] [Abstract][Full Text] [Related]
16. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.
De P; Carlson J; Leyland-Jones B; Dey N
Oncotarget; 2014 Jul; 5(13):4581-602. PubMed ID: 25015035
[TBL] [Abstract][Full Text] [Related]
18. [Expression of cancerous inhibitor of protein phosphatase 2A in tissue microarray of colorectal cancer and its clinical significance].
Peng XY; Chen W; Zhou K; Fu JP; Fu P; Zeng QL
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1102-6. PubMed ID: 24277410
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer.
Birkman EM; Elzagheid A; Jokilehto T; Avoranta T; Korkeila E; Kulmala J; Syrjänen K; Westermarck J; Sundström J
Cancer Med; 2018 Mar; 7(3):698-706. PubMed ID: 29441695
[TBL] [Abstract][Full Text] [Related]
20. EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells.
Liu CY; Huang TT; Huang CT; Hu MH; Wang DS; Wang WL; Tsai WC; Lee CH; Lau KY; Yang HP; Chen MH; Shiau CW; Tseng LM; Chen KF
Eur J Cancer; 2017 Feb; 72():112-123. PubMed ID: 28027514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]